Biological markers in Alzheimer disease

Area of Science:

• Biomarkers and Disease Progression
• Neurodegenerative Diseases
• Alzheimer Disease Pathophysiology

Background:

• Alzheimer disease (AD) has a prolonged preclinical phase, offering a window for intervention.
• Early detection of AD is critical for potentially modifying disease course.
• Identifying predisposing factors and early-stage markers is key to effective management.

Purpose of the Study:

• To review current biological markers for Alzheimer disease.
• To examine predisposing factors, laboratory markers, and diagnostic markers.
• To assess the utility and limitations of various Alzheimer disease markers.

Main Methods:

• Review of genetic risk factors and homocysteine levels.
• Analysis of laboratory markers including amyloid beta and tau protein.
• Evaluation of neuroimaging techniques for structural and functional assessment.

Main Results:

• Numerous markers have been investigated, but many lack consistent validation.
• Current diagnostic tests can be complex, expensive, or require specialized expertise.
• Some markers are only effective in later stages of Alzheimer disease.

Conclusions:

• The ongoing search for reliable Alzheimer disease markers enhances our understanding of its biology.
• New directions in marker research hold promise for improved diagnostics and therapeutics.
• Developing accessible and validated markers is essential for early Alzheimer disease intervention.